American Century Companies’s Vir Biotechnology VIR Stock Holding History

American Century Companies's VIR Position: Q2 2026 in Review

American Century Companies increased its Vir Biotechnology (VIR) stake by 18% in Q2 2026, buying an estimated $497K and bringing the position to 349,020 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

American Century Companies first reported a position in VIR in Q2 2022 and has held it in 17 quarters since. The position peaked at $36.3M in Q2 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

• American Century Companies held 349,020 shares of Vir Biotechnology worth $3.56M as of Q2 2026.
• American Century Companies bought 52,196 Vir Biotechnology shares in Q2 2026, an estimated $497K.
• Vir Biotechnology made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2009 holding.
• American Century Companies first reported a position in Vir Biotechnology in Q2 2022 and has held it in 17 quarters since.
• American Century Companies's Vir Biotechnology position peaked at $36.3M in Q2 2023.
• 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.